| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_076fc0987140c3a10e68bea0b5c98e22
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_26bede77e24d775fb3535b17a75793ac
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_9fc39c73789f9144fa2b28524c8881bf
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_fab9754adbd2eee7751609959d37fce3
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_438f7db5257a58d554213f50a4ab92b6 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2333-988 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-435
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-57438
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-574
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N9-88
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Y402-01011
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-40 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K16-40
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-435
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-574 |
| filingDate |
2007-09-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2e4804fd4e2bfb96ec666b6a0bbd9834
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7afe8806e0164a2821b8901e3153a161
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d623025ae725e573c62d46fa70c5622e |
| publicationDate |
2008-04-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
WO-2008037792-A1 |
| titleOfInvention |
Novel antigens and antibodies associated to pancreatic ductal adenocarcinoma |
| abstract |
The present invention provides novel human protein antigens and related antibodies that have been identified as being specifically expressed in association to human Pancreatic Ductal Adenocarcinoma (PDA). In particular, novel phosphorylated isoforms of alpha-enolase have been identified in transformed cell lines of pancreat ic origin and antibodies binding such isoforms are specifically present in the sera of PDA patients. These proteins and antibodies can be useful for the diagnosis and the treatment of PDA and other cancers having common molecular features. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8895697-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/IT-TO20090697-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2011030302-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2012500964-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2656153-C1 |
| priorityDate |
2006-09-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |